drugset / Trial / NCT01825811
Efficacy and Safety Study of TissueGene-C Mixed With Fibrin-glue for the Patients With Degenerative Arthritis
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to determine whether TissueGene-C, allogeneic human chondrocytes expressing Transforming Growth Factor(TGF)-b1, mixed with fibrin-glue is effective and safe in patients with degenerative arthritis.
Timeline
- Start
- 2012-10
- Primary completion
- 2014-04
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TissueGene-C | Cell therapy | 1 cells | — |
| Subject | TissueGene-C | Cell therapy | 3 cells | — |